Curated MiRNA

DataTables

MiRNA Compound Condition Effect Throughput PMID Details
miR-200c Erlotinib epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) Sensitive High 22045191
miR-200c Erlotinib pancreatic adenocarcinoma Sensitive High 23918833
miR-200c Erlotinib non-small cell lung cancer Resistant Low 23963283